PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3493 (108th)

Medical Devices Technical Corrections Act

referredUnited States· United States Congress· EN

Introduced

17 November 2003

Last action

28 January 2004 · Introduced

Status

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Rep. Greenwood, James C. [R-PA-8], Anna Eshoo

Subjects

Healthcare

Source updated

21 April 2025

Healthcare

Summary

Medical Devices Technical Corrections Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act, as amended by the Medical Device User Fee and Modernization Act of 2002, to revise medical device fee schedule provisions. Revises facility inspection and accredited inspector provisions, including permitting a company that markets at least one medical device in the United States and one medical device in another country to satisfy inspection requirements by: (1) certifying that a foreign country recognizes Food and Drug Administration (FDA) inspection; and/or (2) marketing its devices in a country that recognizes third party inspectors. (Current law requires a company to meet both requirements.) Eliminates the provision deeming a device introduced into interstate commerce within 18 months of enactment of the Medical Device User Fee and Modernization Act of 2002 (October 26, 2002) to be misbranded if the identification of the manufacturer is not conspicuously displayed. Requires (currently authorizes) the Secretary of Health and Human Services to conduct or support research on the long-term effects of silicone breast implants. Permits a person to sell a device under the humanitarian exemption from certain effectiveness requirements for more than its research, fabrication, and distribution costs if such device is intended for pediatric treatment or diagnosis. (Defines "pediatric patient" as a patient under 15 years old at the time of treatment or diagnosis.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 17 November 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 17 November 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 17 November 2003

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  4. 4 December 2003

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 27 January 2004

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  6. 27 January 2004

    Vote

    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 333 - 0 (Roll no. 7). (CR H109-110)

    Source: Floor

  7. 27 January 2004

    Vote

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 333 - 0 (Roll no. 7).(CR H109-110)

    Source: Floor

  8. 27 January 2004

    Floor

    Considered under suspension of the rules. (consideration: CR H109-112)

    Source: Floor

  9. 27 January 2004

    Vote

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

    Source: Floor

  10. 27 January 2004

    Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 3493.

    Source: Floor

  11. 27 January 2004

    Floor

    Mr. Greenwood moved to suspend the rules and pass the bill.

    Source: Floor

  12. 28 January 2004

    Introduced

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

8 official files

Referred in Senate (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.